Your Article Summary
Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor
Obesity Reviews, 07/02/09
Tzotzas T et al. - The article presents the state of knowledge on the implication of PLTP in lipoprotein metabolism, on its atherogenic potential, and the complexity of its implication in obesity, insulin resistance and T2DM.
Related Articles
Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
Arteriosclerosis, Thrombosis, and Vascular Biology, 11/17/09
Relevance Score: 66%
Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects
Atherosclerosis, 10/08/09
Relevance Score: 66%
Vaccination, atherosclerosis and systemic lupus erythematosus
Lupus, 11/05/09
Relevance Score: 65%
Increased Apolipoprotein AI Production Rate and Redistribution of High-Density Lipoprotein Size Induced by Estrogen plus Progestin as Oral Contraceptive
Journal of Clinical Endocrinology and Metabolism, 11/11/09
Relevance Score: 64%
Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study
International Journal of Obesity, 10/16/09
Relevance Score: 62%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with Chronic Kidney Disease: a randomised controlled trial
BMC Nephrology, 12/11/09
FGF23–parathyroid interaction: implications in chronic kidney disease
Kidney International, 12/10/09
Autoimmune Thyroid Disease in Pregnancy: A Review
Journal of Women's Health, 12/10/09

See Latest Articles